References
- Nichols W C, Liepnicks J J, McKusick V A, Benson M D. Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics 1989; 5: 535–540
- Mahloudji M, Teasdall R D, Adamkiewicz J J, Hartmann W H, Lambird P A, McKusick V A. The genetic amyloidoses: With particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type). Medicine 1969; 48: 1–37
- Haliassos A, Chomel J C, Tesson L, Baudis M, Kruh J, Kaplan J C, Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 1989; 17: 3606
- Madisen L, Hoar D I, Holroyd C D, Crisp M, Hodes M E. DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Amer J Med Genet 1987; 27: 379–390
- Jones L A, Skare J C, Cohen A S, Harding J A, Milunsky A, Skinner M. Familial amyloidotic polyneuropathy: A new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clin Genet 1992; 14: 70–73
- Ii S, Minnerath S, Ii K, Dyck P J, Sommer S S. Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations. Neurology 1991; 41: 893–898
- Murrell J, Farlow M, Ghetti B, Benson M D. A mutation in the amyloid precursor protein (APP) associated with hereditary Alzheimer's disease. Science 1991; 254: 97–99
- Uemiehi T, Murrell J R, Zeldenrust S, Benson M D. A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J Med Genet 1992; 29: 888–891
- Zeldenrust S R, Skinner M, Harding J, Skare J C, Benson M D. A new transthyretin variant (His 69) associated with vitreous amyloid in an FAP family. Amyloid: Int J Exp Clin Invest 1994; 1: 17–22
- Jacobson D R, Reveille J D, Buxbaum J N. Frequency and genetic background of the position 122 (Val Ile) variant transthyretin gene in the Black population. Am J Hum Genet 1991; 49: 192–198
- Jacobson D R. A specific test for transthyretin 122 (Val- Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): Confirmation of the gene frequency in Blacks. Am J Hum Genet 1992; 50: 195–198
- Ferlini A, Fini S, Salvi F, Patrosso M C, Vezzoni P, Forabosco A. Molecular strategies in genetic diagnosis of transthyretin-related hereditary amyloidosis. FASEBJ 1992; 6: 2864–2866
- Benson M D, II, Julien J, Liepnieks J, Zeldenrust S, Benson M D. A transthyretin variant (alanine 49) associated with familial amyloidotic polyneuropathy in a French family. J Med Genet 1993; 30: 117–119
- Benson M D, II, Turpin J C, Lucotte G, Zeldenrust S, LeChevalier B, Benson M D. A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family. J Med Genet 1993; 30: 120–122
- Friedman K J, Highsmith W E, Prior T W, Perry T R, Silverman L M. Cystic Fibrosis deletion mutation detected by PCR-mediated site-directed mutagenesis. Clin Chem 1990; 36: 695–696
- Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, Kagawa Y, Kanazawa I, Mannen T. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993; 33: 57–62